Patent · US Active

Rapidly dissolving pharmaceutical composition

US9284341B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2013
Grant dateMar 15, 2016
Priority date
Expiry dateSep 11, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2072
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical dosage form which may comprise carbamoyl glycinated chitosan, and particularly it relates to a pharmaceutical dosage form comprising the novel polymer in a lyophilized polymeric wafer form which shows rapid disintegration and dissolution characteristics in use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.